Bionano Genomics Inc reports results for the quarter ended March 31 - Earnings Summary

• Bionano Genomics Inc BNGO.OQ reported a quarterly adjusted loss of $1.15​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of $-30.60. The mean expectation of three analysts for the quarter was for a loss of $3.02 per share. Wall Street expected results to range from $-3.49 to $-2.45 per share.

• Revenue fell 26.4% to $6.46 million from a year ago; analysts expected $6.23 million.

• Bionano Genomics Inc's reported EPS for the quarter was a loss of $1.15​.

• The company reported a quarterly loss of $3.1 million.

• Bionano Genomics Inc shares had risen by 34.1% this quarter and lost 78.4% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 32.8% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

• Wall Street's median 12-month price target for Bionano Genomics Inc is $7.00

This summary was machine generated from LSEG data May 15 at 10:07 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)